HomeFile

File

AHA 2023 | ORBITA-2: PCI vs. Placebo in Stable Angina for Symptom Reduction

In patients with stable chronic angina, percutaneous coronary intervention (PCI) is often conducted to relieve symptoms. However,...

AHA 2023 | Use of Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Subclinical atrial fibrillation (AF), generally asymptomatic and of short duration, often requires continuous long-term monitoring using pacemakers...

Untreated Aortic Stenosis: Associated Mortality and a Call to Attention

The progression of aortic stenosis has been extensively studied and is well-known. As observed, in its advanced...

Cerebral Embolic Protection Devices: How Useful are they in TAVR?

During TAVR, we often fear the possibility of a stroke, which occurs in approximately 1 – 2%...

Is TAVR Beneficial in Cardiogenic Shock?

The presence of cardiogenic shock (CS) in a setting of aortic stenosis ranges from 1% to 4%....

Acute Pulmonary Thromboembolism: When Anticoagulation Alone May Not Be Enough

In recent times, pulmonary thromboembolism (PTE) has been the subject of growing research due to its persistent...

Renal Denervation is Safe and Reduces Blood Pressure and Medication

We are well aware of the multifactorial nature of hypertension, as well as the fact that it...

Impella in High Risk Coronary Angioplasty before TAVR

The population is aging, which is closely related with the presence of aortic stenosis. This condition, as...